MEDICAMEN BIOTECH
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Medicamen Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-3.88₹ -14.95
As on Jan 16, 2026, 4:01 PM IST
Medicamen Biotech Price Performance
Today's LowToday's High
₹370.55₹387.55
₹370.55
52 Weeks' Low52 Weeks' High
₹292.50₹560.00
₹370.55
Open Price
₹385.25
Prev. Close
₹385.50
Volume
780
Over the last 5 years, the share price of Medicamen Biotech has declined 3.72% CAGR. Over the past year, the corresponding return has been -22.09%.
Medicamen Biotech’s current P/E of 49.49x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Medicamen Biotech Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Medicamen Biotech | -7.36 | -6.78 | 15.15 | -3.92 | -22.09 | -23.66 | -3.72 |
| Sun Pharmaceutical Industries | -5.24 | -7.12 | 0.92 | -3.39 | -4.99 | 17.25 | 22.54 |
| Divi's Laboratories | -5.49 | -1.78 | -5.14 | -8.17 | 6.06 | 23.21 | 11.34 |
| Torrent Pharmaceuticals | -0.16 | 6.29 | 13.77 | 16.84 | 25.03 | 36.80 | 24.26 |
| Cipla | -4.29 | -7.25 | -10.27 | -6.23 | -3.38 | 9.66 | 11.16 |
| Lupin | -0.74 | 4.02 | 12.03 | 11.42 | 2.16 | 42.16 | 14.74 |
| Dr. Reddy's Laboratories | -2.34 | -7.90 | -4.32 | -6.49 | -11.94 | 10.87 | 2.52 |
| Mankind Pharma | -3.68 | 1.43 | -11.13 | -18.05 | -16.25 | 15.14 | 8.83 |
| Zydus Lifesciences | -4.39 | -5.80 | -11.20 | -10.27 | -11.88 | 25.50 | 12.20 |
| Alkem Laboratories | 0.75 | 3.98 | 4.79 | 18.38 | 12.29 | 24.33 | 13.48 |
| Aurobindo Pharma | -3.29 | -1.55 | 5.22 | 1.31 | 1.72 | 37.78 | 4.51 |
| Abbott India | -1.97 | -0.43 | -6.73 | -19.08 | 0.04 | 8.01 | 13.12 |
| Laurus Labs | -2.23 | 7.17 | 22.93 | 30.14 | 93.28 | 44.84 | 23.83 |
| Biocon | -0.26 | -3.48 | 5.84 | -3.40 | -1.43 | 14.59 | -3.77 |
| Glenmark Pharmaceuticals | -3.74 | 0.77 | 5.68 | -10.16 | 35.45 | 68.26 | 31.32 |
| GlaxoSmithKline Pharmaceuticals | -2.14 | -8.84 | -14.22 | -26.64 | 14.88 | 21.70 | 9.14 |
| Ipca Laboratories | -2.08 | 4.81 | 16.07 | 2.76 | -3.49 | 20.31 | 7.43 |
| Anthem Biosciences | -4.54 | -11.92 | -20.64 | -15.72 | -15.72 | -5.54 | -3.36 |
| Ajanta Pharma | -5.42 | 1.59 | 11.29 | -0.72 | -6.90 | 31.63 | 18.15 |
| Emcure Pharmaceuticals | 2.63 | 11.84 | 14.79 | 14.78 | 14.60 | 4.75 | 2.83 |
Over the last one year, Medicamen Biotech has declined 22.09% compared to peers like Sun Pharmaceutical Industries (-4.99%), Divi's Laboratories (6.06%), Torrent Pharmaceuticals (25.03%). From a 5 year perspective, Medicamen Biotech has underperformed peers relative to Sun Pharmaceutical Industries (22.54%) and Divi's Laboratories (11.34%).
Medicamen Biotech Financials
Medicamen Biotech Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 392.73 | 388.92 |
| 10 | 384.67 | 386.23 |
| 20 | 382.37 | 384.88 |
| 50 | 392.08 | 381.69 |
| 100 | 363.21 | 380.06 |
| 200 | 392.35 | 396.25 |
Medicamen Biotech Share Holding Pattern
In the latest quarter, Medicamen Biotech remained same as its previous close in promoter holding, while DII stake decreased to 0.59%, FII holding rose to 0.05%, and public shareholding moved up to 58.84% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Medicamen Biotech Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 16, 2026, 6:07 AM IST | Medicamen Biotec - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 07, 2026, 9:29 PM IST | Medicamen Biotec - Announcement Under Regulation 30 (LODR)- EU Approval For Product Registration Of Paracetamol |
| Nov 14, 2025, 9:53 PM IST | Medicamen Biotec - Financial Results For The Quarter And Half Year Ended On September 30, 2025 |
| Nov 05, 2025, 10:07 PM IST | Medicamen Biotec - Board Meeting Intimation for Consideration Of Unaudited Consolidated And Standalone Financial Results Of T |
| Oct 25, 2025, 10:52 PM IST | Medicamen Biotec - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Medicamen Biotech
Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 151.46 Cr. and Equity Capital is Rs. 12.71 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address1506, Chiranjiv Tower, 43, Nehru Place, New Delhi Delhi 110019
- Contact
Management
- Mr. Rahul BishnoiChairman
- Mr. Ashwani Kumar SharmaNon Executive Director
- Dr. Vimal Kumar ShrawatNon Executive Director
- Mr. Sanjay BansalNon Executive Director
- Mr. Suresh Kumar SinghNon Executive Director
- Mr. Arun KumarIndependent Director
- Mr. Harish PandeIndependent Director
- Ms. Sangeeta BishnoiIndependent Director
- Dr. Ravi Kumar BansalIndependent Director
- Mrs. Sumita DwivediIndependent Director
FAQs on Medicamen Biotech Share Price
What is the share price of Medicamen Biotech?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Medicamen Biotech is ₹370.55 as on Jan 16, 2026.
What kind of stock is Medicamen Biotech?
The Medicamen Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Medicamen Biotech?
The market cap of Medicamen Biotech is ₹502.64 Cr as on Jan 16, 2026.
What are today's High and Low prices of Medicamen Biotech?
Today’s highest and lowest price of Medicamen Biotech are ₹387.55 and ₹370.55.
What are the 52 Week High and 52 Week Low of Medicamen Biotech?
The 52-week high/low is the highest and lowest price at which Medicamen Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Medicamen Biotech is ₹560.00 and 52-week low of Medicamen Biotech is ₹292.50 as on Jan 16, 2026.
How has the Medicamen Biotech performed historically in terms of returns?
The Medicamen Biotech has shown returns of -3.88% over the past day, -6.78% for the past month, 15.15% over 3 months, -22.09% over 1 year, -23.66% across 3 years, and -3.72% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Medicamen Biotech?
P/E ratio of and PB ratio of Medicamen Biotech are 49.49 and 1.83 on Jan 16, 2026. While the company gives a dividend yield of 0.27 per annum.
✕
Market Pulse